A Unique Mutational Spectrum of MLC1 in Korean Patients With Megalencephalic Leukoencephalopathy With Subcortical Cysts: p.Ala275Asp Founder Mutation and Maternal Uniparental Disomy of Chromosome 22.
10.3343/alm.2017.37.6.516
- Author:
Sun Ah CHOI
1
;
Soo Yeon KIM
;
Jihoo YOON
;
Joongmoon CHOI
;
Sung Sup PARK
;
Moon Woo SEONG
;
Hunmin KIM
;
Hee HWANG
;
Ji Eun CHOI
;
Jong Hee CHAE
;
Ki Joong KIM
;
Seunghyo KIM
;
Yun Jin LEE
;
Sang Ook NAM
;
Byung Chan LIM
Author Information
1. Department of Pediatrics, Pediatric Clinical Neuroscience Center, Seoul National University Children's Hospital, Seoul National University College of Medicine, Seoul, Korea. prabbit7@snu.ac.kr
- Publication Type:Original Article
- Keywords:
Megalencephalic leukoencephalopathy with subcortical cysts;
MLC1;
Founder effect;
Korean;
Uniparental disomy
- MeSH:
Alleles;
Chromosomes, Human, Pair 22*;
Comparative Genomic Hybridization;
Exons;
Founder Effect;
Haplotypes;
Humans;
Leukoencephalopathies*;
Loss of Heterozygosity;
Megalencephaly;
Mothers;
Seizures;
Uniparental Disomy*
- From:Annals of Laboratory Medicine
2017;37(6):516-521
- CountryRepublic of Korea
- Language:English
-
Abstract:
BACKGROUND: Megalencephalic leukoencephalopathy with subcortical cysts (MLC) is a rare inherited disorder characterized by infantile-onset macrocephaly, slow neurologic deterioration, and seizures. Mutations in the causative gene, MLC1, are found in approximately 75% of patients and are inherited in an autosomal recessive manner. We analyzed MLC1 mutations in five unrelated Korean patients with MLC. METHODS: Direct Sanger sequencing was used to identify MLC1 mutations. A founder effect of the p.Ala275Asp variant was demonstrated by haplotype analysis using single-nucleotide polymorphic (SNP) markers. Multiple ligation-dependent probe amplification (MLPA) and comparative genomic hybridization plus SNP array were used to detect exonic deletions or uniparental disomy (UPD). RESULTS: The most prevalent pathogenic variant was c.824C>A (p.Ala275Asp) found in 7/10 (70%) alleles. Two pathogenic frameshift variants were found: c.135delC (p.Cys46Alafs*12) and c.337_353delinsG (p.Ile113Glyfs*4). Haplotype analysis suggested that the Korean patients with MLC harbored a founder mutation in p.Ala275Asp. The p.(Ile113Glyfs*4) was identified in a homozygous state, and a family study revealed that only the mother was heterozygous for this variant. Further analysis of MLPA and SNP arrays for this patient demonstrated loss of heterozygosity of chromosome 22 without any deletion, indicating UPD. The maternal origin of both chromosomes 22 was demonstrated by haplotype analysis. CONCLUSIONS: This study is the first to describe the mutational spectrum of Korean patients with MLC, demonstrating a founder effect of the p.Ala275Asp variant. This study also broadens our understanding of the mutational spectrum of MLC1 by demonstrating a homozygous p.(Ile113Glyfs*4) variant resulting from UPD of chromosome 22.
